Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Introduction Myasthenia gravis (MG) is an autoimmune disease characterized by dysfunction at the neuromuscular junction. Treatment frequently includes corticosteroids (CSs) and IV immunoglobulin (IVIG). Treatment of severe MG or exacerbations frequently includes plasma exchange or IV immunoglobulin (IVIG). Plasma exchange was shown to improve muscle strength in patients with MG. Treatment with IVIG was found to produce […]